| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 59,195 | 51,065 | 49,087 | 52,715 | | Cost of Revenue | 25,753 | 18,367 | 19,043 | 16,640 | | | Gross Profit | 33,442 | 32,698 | 30,044 | 36,075 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 17,976 | 18,066 | 15,536 | 15,745 | | Non Recurring | 1,642 | 38,870 |
-
| 2,100 | | Others | 13,868 | 15,381 | 13,056 | 15,777 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (44) | (39,619) | 1,452 | 2,453 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,352 | 13,299 | 167,434 | 408 | | Earnings Before Interest And Taxes | 159,045 | (27,121) | 1,452 | 2,453 | | Interest Expense | 10,793 | 10,560 | 10,430 | 10,804 | | Income Before Tax | 148,252 | (37,681) | (8,978) | (8,351) | | Income Tax Expense | 54 | 11,293 | (3,941) | (4,293) | | Minority Interest |
-
|
-
|
-
| (690) | | | | Net Income From Continuing Ops | (53,339) | (77,534) | 164,217 | (3,172) | | | Non-recurring Events | | Discontinued Operations | 10 | 146 | (7) | 2,554 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (54,970) | (77,388) | 164,210 | (618) | | Preferred Stock And Other Adjustments | (2,118) | (3,925) | (3,639) | (3,520) | | | Net Income Applicable To Common Shares | ($57,088) | ($81,313) | $160,571 | ($4,138) |
|
0.28% Nasdaq 
0.02%
Income Statement
